SB
LLY icon

Strategic Blueprint’s Eli Lilly LLY Stock Holding History

Strategic Blueprint’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$32K – 527
2022
Q3 		$32K Buy
+100
New +$31.7K ﹤0.01% 482

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Strategic Blueprint's LLY Position: Q1 2026 in Review

Strategic Blueprint increased its Eli Lilly (LLY) stake by 1% in Q1 2026, buying an estimated $126K and bringing the position to 12,266 shares worth $11.3M. The position accounts for 0.66% of the portfolio, ranked #31.

Strategic Blueprint first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $13M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Strategic Blueprint held 12,266 shares of Eli Lilly worth $11.3M as of Q1 2026.
  • Strategic Blueprint bought 124 Eli Lilly shares in Q1 2026, an estimated $126K.
  • Eli Lilly made up 0.66% of Strategic Blueprint's portfolio in Q1 2026, its #31 holding.
  • Strategic Blueprint first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Strategic Blueprint's Eli Lilly position peaked at $13M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Strategic Blueprint's 13F filing for Q1 2026, filed 29 Apr 2026.